← Leaderboards
Robert D Christensen
University Of Florida
$1,579,476
Attributed
$1,579,476
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,579,476 · 5
By mechanism
M01$602,826 · 3
R21$587,250 · 1
R01$389,400 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Martha C Sola-Visner$9,992,680
- Donald A Novak$1,961,678
- Lyle L Moldawer$27,709,476
- Sandra E Juul$29,031,851
- Darlene A Calhoun$1,547,631
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchNewborn Human (0-6 Weeks)Recombinant ProteinsHuman Therapy EvaluationPremature Infant HumanPharmacokineticsDosageClinical Trial Phase IDrug Screening /EvaluationIntravenous AdministrationHematopoietic Stem CellsUrinalysisHematopoiesisColony Stimulating FactorClinical TrialsEmbryonic Stem CellDisease /Disorder ModelBrain InjuryHypoxiaDisease /Disorder EtiologyDevelopmental NeurobiologyChemopreventionFree Radicals
Grant awards (16)
High dose erythropoietin for neonates with asphyxia$195,750
R21 · FY2004 · HD
High dose erythropoietin for neonates with asphyxia$195,750
R21 · FY2003 · HD
High dose erythropoietin for neonates with asphyxia$195,750
R21 · FY2002 · HD
PATHOGENESIS OF THROMBOCYTOPENIAS OF NEONATES$128,521
R01 · FY2002 · HL
BLOOD CELL PRODUCTION IN THE PREMATURELY DELIVERED INFANT$207,281
M01 · FY2001 · RR
PHARMACOKINETICS OF INTRAVENOUS RECOMBINANT G-CSF IN NEWBORN INFANTS$207,281
M01 · FY2001 · RR
PATHOGENESIS OF THROMBOCYTOPENIAS OF NEONATES$131,161
R01 · FY2001 · HL
BLOOD CELL PRODUCTION IN THE PREMATURELY DELIVERED INFANT$55,741
M01 · FY2001 · RR
PHARMACOKINETICS OF INTRAVENOUS RECOMBINANT G-CSF IN NEWBORN INFANTS$55,741
M01 · FY2001 · RR
PATHOGENESIS OF THROMBOCYTOPENIAS OF NEONATES$129,718
R01 · FY2000 · HL
PHARMACOKINETICS OF INTRAVENOUS RECOMBINANT G-CSF IN NEWBORN INFANTS$38,391
M01 · FY2000 · RR
BLOOD CELL PRODUCTION IN THE PREMATURELY DELIVERED INFANT$38,391
M01 · FY2000 · RR
PHARMACOKINETICS OF INTRAVENOUS RECOMBINANT G-CSF IN NEWBORN INFANTS$0
M01 · FY2000 · RR
PROPHYLACTIC PLATELET TRANSFUSION IN NEONATAL ICU$0
M01 · FY2000 · RR
PROPHYLACTIC PLATELET TRANSFUSION IN NEONATAL ICU$0
M01 · FY2000 · RR
BLOOD CELL PRODUCTION IN THE PREMATURELY DELIVERED INFANT$0
M01 · FY2000 · RR